• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

POEMS 综合征相关肺动脉高压

Pulmonary hypertension in POEMS syndrome.

机构信息

Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.

出版信息

Haematologica. 2013 Mar;98(3):393-8. doi: 10.3324/haematol.2012.073031. Epub 2012 Sep 14.

DOI:10.3324/haematol.2012.073031
PMID:22983590
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3659947/
Abstract

POEMS syndrome is a rare clonal plasma cell disease. Patients with POEMS syndrome are at risk of developing pulmonary hypertension, but the data on its incidence and impact on outcome are limited. We reviewed records of 154 POEMS syndrome patients with complete duplex echocardiography data for estimation of pulmonary artery systolic pressure (sPAP) at the time of diagnosis. Forty-two (27%) of 154 patients with pulmonary hypertension (estimated sPAP ≥50 mmHg) were identified. Median age was 46 years (range 31-71 years). Patients with pulmonary hypertension were more likely to have peripheral edema (P=0.04), ascites (P=0.02), pleural effusion (P=0.005), and have longer time from onset to diagnosis (P=0.004) when compared with those without pulmonary hypertension. Restrictive abnormalities and decreased diffusion capacity of carbon monoxide were observed in 83% and 96% patients with pulmonary hypertension, compared with 50% and 72% in patients without pulmonary hypertension, respectively. Reversibility of pulmonary hypertension was observed after treatment of POEMS syndrome. After median follow of 32 months, survival of patients with pulmonary hypertension was worse than those without (median overall survival 54 months vs. median not reached, P=0.021). In conclusion, pulmonary hypertension is a common feature of POEMS syndrome, and is associated with signs of extravascular volume overload. Although active treatment of POEMS syndrome can reverse pulmonary hypertension, survival of these patients is worse than those without pulmonary hypertension.

摘要

POEMS 综合征是一种罕见的克隆性浆细胞疾病。POEMS 综合征患者有发生肺动脉高压的风险,但关于其发病率及其对预后影响的数据有限。我们回顾了 154 例 POEMS 综合征患者的记录,这些患者均有完整的双功能超声心动图数据,用于评估诊断时的肺动脉收缩压(sPAP)。在 154 例患者中,有 42 例(27%)患有肺动脉高压(估计 sPAP≥50mmHg)。中位年龄为 46 岁(范围 31-71 岁)。与无肺动脉高压的患者相比,有肺动脉高压的患者更有可能出现外周水肿(P=0.04)、腹水(P=0.02)、胸腔积液(P=0.005)和从发病到诊断的时间更长(P=0.004)。与无肺动脉高压的患者相比,有肺动脉高压的患者分别有 83%和 96%观察到限制性异常和一氧化碳弥散量降低,而无肺动脉高压的患者分别为 50%和 72%。POEMS 综合征治疗后可观察到肺动脉高压的逆转。在中位随访 32 个月后,有肺动脉高压的患者的生存情况比无肺动脉高压的患者差(中位总生存期 54 个月与未达到,P=0.021)。总之,肺动脉高压是 POEMS 综合征的一个常见特征,与血管外容量超负荷的迹象有关。尽管积极治疗 POEMS 综合征可以逆转肺动脉高压,但这些患者的生存情况比无肺动脉高压的患者差。

相似文献

1
Pulmonary hypertension in POEMS syndrome.POEMS 综合征相关肺动脉高压
Haematologica. 2013 Mar;98(3):393-8. doi: 10.3324/haematol.2012.073031. Epub 2012 Sep 14.
2
Pulmonary manifestations in patients with POEMS syndrome: a retrospective review of 137 patients.POEMS综合征患者的肺部表现:137例患者的回顾性研究
Chest. 2008 Apr;133(4):969-74. doi: 10.1378/chest.07-1800. Epub 2008 Jan 15.
3
Pulmonary morbidity improves after autologous stem cell transplantation in POEMS syndrome.POEMS综合征患者自体干细胞移植后肺部发病率改善。
Respir Med. 2015 Jan;109(1):122-30. doi: 10.1016/j.rmed.2014.11.005. Epub 2014 Nov 14.
4
Pulmonary hypertension associated with POEMS syndrome.与POEMS综合征相关的肺动脉高压。
Eur Respir J. 1996 Aug;9(8):1760-2. doi: 10.1183/09031936.96.09081760.
5
POEMS syndrome: definitions and long-term outcome.POEMS综合征:定义与长期预后
Blood. 2003 Apr 1;101(7):2496-506. doi: 10.1182/blood-2002-07-2299. Epub 2002 Nov 27.
6
Pulmonary hypertension in POEMS syndrome: a new feature mediated by cytokines.POEMS综合征中的肺动脉高压:一种由细胞因子介导的新特征。
Am J Respir Crit Care Med. 1998 Mar;157(3 Pt 1):907-11. doi: 10.1164/ajrccm.157.3.9707095.
7
Pulmonary manifestations of POEM syndrome: a retrospective analysis of 282 cases.POEM 综合征的肺部表现:282 例回顾性分析。
BMC Pulm Med. 2023 Nov 23;23(1):465. doi: 10.1186/s12890-023-02741-9.
8
A prospective phase II study of low dose lenalidomide plus dexamethasone in patients with newly diagnosed polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes (POEMS) syndrome.一项前瞻性 II 期研究,评估低剂量来那度胺联合地塞米松治疗新诊断的多发性神经病、器官肿大、内分泌病、单克隆丙种球蛋白病和皮肤改变(POEMS)综合征患者的疗效。
Am J Hematol. 2018 Jun;93(6):803-809. doi: 10.1002/ajh.25100. Epub 2018 Apr 18.
9
POEMS Syndrome: 2019 Update on diagnosis, risk-stratification, and management.POEMS 综合征:2019 年关于诊断、风险分层和管理的更新。
Am J Hematol. 2019 Jul;94(7):812-827. doi: 10.1002/ajh.25495. Epub 2019 May 23.
10
Clinical characteristics and the long-term outcome of patients with atypical POEMS syndrome variant with undetectable monoclonal gammopathy.不伴单克隆丙种球蛋白血症的非典型 POEMS 综合征变异患者的临床特征和长期预后。
Ann Hematol. 2019 Mar;98(3):735-743. doi: 10.1007/s00277-018-03589-4. Epub 2019 Jan 5.

引用本文的文献

1
Capillary leak phenotype as a major cause of death in patients with POEMS syndrome.毛细血管渗漏表型是POEMS综合征患者死亡的主要原因。
Leukemia. 2025 Mar;39(3):703-709. doi: 10.1038/s41375-024-02489-z. Epub 2024 Dec 16.
2
Pulmonary manifestations of POEM syndrome: a retrospective analysis of 282 cases.POEM 综合征的肺部表现:282 例回顾性分析。
BMC Pulm Med. 2023 Nov 23;23(1):465. doi: 10.1186/s12890-023-02741-9.
3
Effects of short-term water velocity stimulation on the biochemical and transcriptional responses of grass carp ().短期水流速度刺激对草鱼生化和转录反应的影响()。 (注:原文括号处内容缺失,翻译时保留原样)
Front Physiol. 2023 Aug 31;14:1248999. doi: 10.3389/fphys.2023.1248999. eCollection 2023.
4
Pulmonary hypertension in patients with multiple myeloma: A comprehensive review.多发性骨髓瘤患者的肺动脉高压:全面综述
Pulm Circ. 2023 Apr 1;13(2):e12210. doi: 10.1002/pul2.12210. eCollection 2023 Apr.
5
Association of Pulmonary Hypertension and Monoclonal Gammopathy of Undetermined Significance.肺动脉高压与意义未明的单克隆丙种球蛋白病的关联
Adv Hematol. 2022 Nov 18;2022:8918959. doi: 10.1155/2022/8918959. eCollection 2022.
6
Comprehensive Diagnosis and Management of POEMS Syndrome.POEMS综合征的综合诊断与管理
Hemasphere. 2022 Oct 31;6(11):e796. doi: 10.1097/HS9.0000000000000796. eCollection 2022 Nov.
7
Update on the POEMS syndrome.POEMS综合征的最新进展。
Blood Res. 2022 Apr 30;57(S1):27-31. doi: 10.5045/br.2022.2022001.
8
Echocardiography-defined pulmonary hypertension is an adverse prognostic factor for newly diagnosed multiple myeloma patients.超声心动图定义的肺动脉高压是新诊断多发性骨髓瘤患者的不良预后因素。
Cancer Med. 2022 Nov;11(22):4182-4192. doi: 10.1002/cam4.4770. Epub 2022 Apr 24.
9
Effective treatment of polyneuropathy, organomegaly, endocrinopathy, M-protein, and skin changes syndrome with congestive heart failure: A case report.多神经病、器官肿大、内分泌病、M蛋白血症和皮肤改变综合征合并充血性心力衰竭的有效治疗:一例报告
World J Clin Cases. 2021 Sep 6;9(25):7504-7511. doi: 10.12998/wjcc.v9.i25.7504.
10
Congestive heart failure associated with POEMS syndrome that was adequately distinguished from cardiac amyloidosis: a case report and literature review.与POEMS综合征相关的充血性心力衰竭,已与心脏淀粉样变性充分区分:一例病例报告及文献综述
Ann Transl Med. 2021 Aug;9(15):1266. doi: 10.21037/atm-21-1071.

本文引用的文献

1
Long-term outcomes after autologous stem cell transplantation for patients with POEMS syndrome (osteosclerotic myeloma): a single-center experience.POEMS 综合征(硬化性骨髓瘤)患者自体干细胞移植后的长期结果:单中心经验。
Blood. 2012 Jul 5;120(1):56-62. doi: 10.1182/blood-2012-04-423178. Epub 2012 May 18.
2
POEMS syndrome: 2011 update on diagnosis, risk-stratification, and management.POEMS 综合征:诊断、风险分层和治疗的 2011 年更新。
Am J Hematol. 2011 Jul;86(7):591-601. doi: 10.1002/ajh.22050.
3
Combination of melphalan and dexamethasone for patients with newly diagnosed POEMS syndrome.马法兰和地塞米松联合治疗新诊断的 POEMS 综合征患者。
Blood. 2011 Jun 16;117(24):6445-9. doi: 10.1182/blood-2010-12-328112. Epub 2011 Mar 10.
4
Clinical characteristics and long-term outcome of patients with POEMS syndrome in China.中国 POEMS 综合征患者的临床特征和长期预后。
Ann Hematol. 2011 Jul;90(7):819-26. doi: 10.1007/s00277-010-1149-0. Epub 2011 Jan 8.
5
Systemic corticosteroids as first-line treatment in pulmonary hypertension associated with POEMS syndrome.POEMS 综合征相关肺动脉高压的一线治疗药物为全身皮质类固醇。
J Bras Pneumol. 2009 Aug;35(8):804-8. doi: 10.1590/s1806-37132009000800013.
6
Guidelines for the diagnosis and treatment of pulmonary hypertension.肺动脉高压诊断与治疗指南。
Eur Respir J. 2009 Dec;34(6):1219-63. doi: 10.1183/09031936.00139009. Epub 2009 Sep 12.
7
Accuracy of Doppler echocardiography in the hemodynamic assessment of pulmonary hypertension.多普勒超声心动图在肺动脉高压血流动力学评估中的准确性。
Am J Respir Crit Care Med. 2009 Apr 1;179(7):615-21. doi: 10.1164/rccm.200811-1691OC. Epub 2009 Jan 22.
8
Pulmonary manifestations in patients with POEMS syndrome: a retrospective review of 137 patients.POEMS综合征患者的肺部表现:137例患者的回顾性研究
Chest. 2008 Apr;133(4):969-74. doi: 10.1378/chest.07-1800. Epub 2008 Jan 15.
9
Treatment of POEMS syndrome with bevacizumab.贝伐单抗治疗POEMS综合征
Haematologica. 2007 Oct;92(10):1438-9. doi: 10.3324/haematol.11315.
10
POEMS syndrome.POEMS综合征。
Blood Rev. 2007 Nov;21(6):285-99. doi: 10.1016/j.blre.2007.07.004. Epub 2007 Sep 11.